Dr. Reddy’s Laboratories has been granted a patent for crystalline forms of a 3-substituted 1,2,4-oxadiazole compound. The patent also covers methods of preparation and related pharmaceutical, veterinary, and agriculturally-relevant uses. GlobalData’s report on Dr. Reddy’s Laboratories gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Dr. Reddy's Laboratories, cancer treatment biomarkers was a key innovation area identified from patents. Dr. Reddy's Laboratories's grant share as of June 2023 was 1%. Grant share is based on the ratio of number of grants to total number of patents.
Crystalline forms of a 3-substituted 1,2,4-oxadiazole compound
A recently granted patent (Publication Number: US11680051B2) describes a method for preparing a crystalline compound with a specific chemical structure. The method involves preparing a solution by filtering a suspension containing the compound. The solvent used in the process can be selected from a range of options including acetonitrile, anisole, dichloromethane, ethanol, isopropyl acetate, methyl tert-butyl ether (MTBE), n-heptane, tetrahydrofuran, water, and mixtures thereof.
The patent also mentions that the purity of the resulting crystalline compound can vary, with options ranging from about 90% to about 99%. Additionally, the compound can exist in different forms, such as solvates or hydrates. In particular, it can be a monohydrate.
The patent further provides specific 2? values for the crystalline compound, which are indicative of its crystal structure. These values include 8.4±0.2, 13.6±0.2, 16.5±0.2, 16.8±0.2, 21.4±0.2, and 28.4±0.2. Other sets of 2? values are also mentioned, such as 8.4±0.2, 13.6±0.2, 16.5±0.2, 16.8±0.2, 19.3±0.2, 20.4±0.2, 21.4±0.2, and 28.4±0.2.
The patent includes a method for preparing the crystalline compound, which involves using the same solvents and purity ranges as mentioned earlier. The resulting compound can have the same crystal structure and 2? values as described in the previous claims.
In addition to the method, the patent also claims the crystalline compound itself, with the same chemical structure and purity options as mentioned before.
Overall, this patent provides a detailed method for preparing a specific crystalline compound, along with its various forms and specific crystal structure. The patent's claims cover both the method and the resulting compound, offering potential applications in various industries such as pharmaceuticals, materials science, and chemical synthesis.
To know more about GlobalData’s detailed insights on Dr. Reddy's Laboratories, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
